Summary
- Current Price
- As of today, SPRY price is $9.06, down -0.66% on
- Current Price All-Time High
- SPRY price is currently -85.71% below its historical high of $63.41 set on
- Market Cap
- SPRY current market cap is $896M, down -15.27% year-over-year
- PE Ratio
- SPRY PE ratio is unknown
- Revenue
- SPRY current annual revenue is $89.15M, up +297063.33% year-over-year
- Next Earnings
- The next earnings release for SPRY is on
Profile
| Metric | Value |
|---|---|
| Full Name | ARS Pharmaceuticals, Inc. |
| Ticker | NASDAQ: SPRY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ars-pharma.com |
| Employees | 155 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $9.06 | |
| Price, 1D Change | -0.66% | |
| $896M | ||
| - | ||
| - | ||
| 0.93 | ||
| $89M | ||
| Revenue, 1Y Change | +297,063.33% | |
| $0.08 | ||
| EPS, 1Y Change | +113.68% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | SBTX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.08 | ||
| EPS Estimate | -$1.80 | |
| EPS Est. Change | -2,404.74% | |
| $89.15M | ||
| Revenue Estimate | $81.68M | |
| Revenue Est. Change | -8.37% | |
| Current Price | $9.06 | |
| Price Target | - | $31.00 |
| Price Tgt. Change | - | +242.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.64 | -$0.57 | +10.78% | |
| -$0.56 | $0.08 | +113.95% | |
| -$1.80 | N/A | -2,404.74% | |
| -$1.47 | N/A | -1,985.40% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $10.00K | $30.00K | +200.00% | |
| $18.48M | $89.15M | +382.41% | |
| $81.68M | N/A | -8.37% | |
| $172.72M | N/A | +93.74% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $9.06 | |
| $12.06 | ||
| SMA 200 vs Price | +33.13% | |
| $10.25 | ||
| SMA 50 vs Price | +13.17% | |
| 0.93 | ||
| $0.50 | ||
| 42.07 | ||
| 26.83% | ||
| 71.49% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $89.15M | ||
| $0.08 | ||
| $87.96M | ||
| 98.67% | ||
| -$3.08M | ||
| -3.46% | ||
| $8.00M | ||
| 8.97% | ||
| -$2.88M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 14.26 | ||
| 14.04 | ||
| - | ||
| 1 | ||
| 6.49 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 6.27 | ||
| 6.07 | ||
| -7.86 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $256.80M | ||
| $314.02M | ||
| $351.15M | ||
| $334.30M | ||
| $94.36M | ||
| $23.44M | ||
| $42.00K | ||
| $42.00K | ||
| $9.87M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $81.15M | ||
| $91.05M | ||
| $1.19M | ||
| $0.00 | ||
| $79.00K | ||
| $0.00 | ||
| $288.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $13.55M | ||
| -$106.10M | ||
| $72.40M | ||
| $563.00K | ||
| $12.99M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Roth Capital | ||
| Scotiabank | ||
| Raymond James | → | |
| Leerink Partners | → | |
| Cantor Fitzgerald | → | |
| Leerink Partners | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | ||
| Raymond James | → |
Analyst sentiment
Institutional ownership
Screeners with SPRY
FAQ
What is the ticker symbol for ARS Pharmaceuticals, Inc.?
The ticker symbol for ARS Pharmaceuticals, Inc. is NASDAQ:SPRY
Does ARS Pharmaceuticals, Inc. pay dividends?
No, ARS Pharmaceuticals, Inc. does not pay dividends
What sector is ARS Pharmaceuticals, Inc. in?
ARS Pharmaceuticals, Inc. is in the Healthcare sector
What industry is ARS Pharmaceuticals, Inc. in?
ARS Pharmaceuticals, Inc. is in the Biotechnology industry
What country is ARS Pharmaceuticals, Inc. based in?
ARS Pharmaceuticals, Inc. is headquartered in United States
When did ARS Pharmaceuticals, Inc. go public?
ARS Pharmaceuticals, Inc. initial public offering (IPO) was on December 4, 2020
Is ARS Pharmaceuticals, Inc. in the S&P 500?
No, ARS Pharmaceuticals, Inc. is not included in the S&P 500 index
Is ARS Pharmaceuticals, Inc. in the NASDAQ 100?
No, ARS Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is ARS Pharmaceuticals, Inc. in the Dow Jones?
No, ARS Pharmaceuticals, Inc. is not included in the Dow Jones index
When was ARS Pharmaceuticals, Inc. last earnings report?
ARS Pharmaceuticals, Inc.'s most recent earnings report was on November 10, 2025
When does ARS Pharmaceuticals, Inc. report earnings?
The next expected earnings date for ARS Pharmaceuticals, Inc. is March 9, 2026
Data Sources & References
- SPRY Official Website ars-pharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1671858/000119312525273111/0001193125-25-273111-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1671858/000095017025042320/0000950170-25-042320-index.htm
- SPRY Profile on Yahoo Finance finance.yahoo.com/quote/SPRY
- SPRY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/spry